Groundbreaking Malaria Vaccine under Test
Why in news?
- The World Health Organisation welcomed a pilot project in Malawi of administering a malaria vaccine to children below the age of 2 years. A total 3,60,000 children across three African countries — Malawi, Ghana and Kenya — will be covered every year with the vaccine.
What is the RTS, S (Mosquirix) vaccine?
- RTS, S/AS01 (trade name Mosquirix) is a recombinant protein-based malaria vaccine.
- A pilot project for vaccination has been launched on April 23, 2019 in Malawi. Ghana and Kenya are to join the program later this year.
- The vaccine has been developed by GSK (GlaxoSmithKline ) ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 Chemical Parks to Power India’s Manufacturing and Sustainability Push
- 2 Decarbonising the Steel Sector: An Economic Necessity & Environmental Obligation for India
- 3 16th FC Report: Recommendations and Emerging Concerns
- 4 Ethanol Blending: Rising Tensions between Aatmanirbharta in Energy and Aatmanirbharta in Food
- 5 PRAHAAR: Shaping a New Era of Proactive Counter-Terrorism
- 6 Menstrual Health as a Facet of Right to Life: SC
- 7 From Energy Dependence to Economic Interdependence: Reframing India-Arab Trade Relations
- 8 National Security and Public Order vs Freedom of Art and Expression
- 9 New Delhi Declaration on AI Impact: India’s Roadmap for AI’s Future
- 10 India Semiconductor Mission 2.0: Strengthening India’s Chip Ecosystem
